Persons | Marinebiotech

marinebiotech.eu/persons?module=project&proid=4104

Persons

[ report an error in this record ] Print this page

EUROpean network of trans-national collaborative RTD projects in the field of NANOMEDicine
www.euronanomed.net/

Acronym: EuroNanoMed
Period: January 2009 till December 2012
Status: Completed
 Institutes 

Institutes (22)  Top 
  • Ministério da Ciência e da Tecnologia; Foundation for Science and Technology (FCT), more
    • Resende, Catarina
  • Swedish Research Council (VR), more
  • Scientific and Technological Research Council of Turkey (TÜBITAK), more
  • Ministry of the Walloon Region; Directorate general of Technologies, Research and Energy (DGTRE)
  • Atomic Energy and Alternative Energies Commission (CEA), more
  • INNObasque, more
  • Federal Ministry of Education and Research (BMBF), more
  • French National Research Agency (ANR), more
  • The Icelandic Centre for Research (RANNIS), more
  • Spanish Ministry of Economy and Competiveness; Instituto de Salud Carlos III (ISCIII), more
  • Latvian Academy of Sciences (LAS), more
  • Ministry of health; Chief Scientist Office (CSO), more
  • Ministry of Education, Research, Innovation, Youth and Sport; National Authority for Scientific Research (ANCS), more
  • National Centre for Programme Management (NCPM), more
  • National Centre for Research and Development (NCBiR), more
  • Hungarian National Office for Research and Technology (NKTH), more
  • Research Council of Lithuania (RCL), more
  • Sweden's Innovation Agency (VINNOVA), more
  • Swiss National Science Foundation (SNSF), more
  • Spanish Ministry of Economy and Competiveness (MINECO), more
  • The Association of German Engineers; VDI Technologiezentrum GmbH (VDItz), more
  • Veneto Nanotech, more

Abstract
Nanomedicine is the application of nanotechnology to medicine and healthcare. The field takes advantage of the physical, chemical and biological properties of materials at the nanometer scale to be used for diagnosis, treatment and follow-up of diseases. Given the immense potential impact of nanomedicine on public wellbeing and on economic growth, the field is of considerable strategic importance for Europe.

The EuroNanoMed ERA-NET initiative comprises 24 partners from 18 countries/regions. EuroNanoMed aims at fostering the competitiveness of European nanomedicine players through the support of trans-national collaborative and multidisciplinary Research and Technology Development (RTD) projects with participants from academia, clinical/public health communities, and industry (particularly small and medium-sized enterprises).

All data in the Integrated Marine Information System (IMIS) is subject to the VLIZ privacy policy Top | Institutes